CONDUIT PHARMACEUTICALS INC. (Nasdaq:CDT)
Health Care/Life Sciences • Pharmaceuticals
CIK 1896212
Company
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.
Address
4581 Tamiami Trail North
Suite 200
Naples, Florida 34103
4581 Tamiami Trail North
Suite 200
Naples, Florida 34103
Employees
7
7
Stock Info
Key Executives
Board Of Directors
Chief Executive Officer & Director David Joszef Tapolczay |
Director Simon Jeremy Fry |
Director Andrew Regan |
Independent Non-Executive Chairman Freda C. Lewis-Hall |
Independent Director Faith L. Charles |
Independent Director Chele Chiavacci Farley |
SEC filings
Date | Form | Event |
---|---|---|
20 Dec, 2024 | 8-K | |
20 Dec, 2024 | 4 | |
20 Dec, 2024 | 4 | |
20 Dec, 2024 | 4 | |
20 Dec, 2024 | 4 | |
20 Dec, 2024 | 3 | |
17 Dec, 2024 | 8-K | |
16 Dec, 2024 | 424B3 | |
9 Dec, 2024 | 424B3 | |
6 Dec, 2024 | DEF 14A | |
6 Dec, 2024 | EFFECT | |
26 Nov, 2024 | PRE 14A | |
25 Nov, 2024 | S-3 | |
25 Nov, 2024 | 8-K | |
20 Nov, 2024 | 4 | |
20 Nov, 2024 | 4 | |
20 Nov, 2024 | 4 | |
20 Nov, 2024 | 4 | |
20 Nov, 2024 | 4 | |
19 Nov, 2024 | 8-K | |
14 Nov, 2024 | 10-Q | |
14 Nov, 2024 | 8-K | |
14 Nov, 2024 | 10-Q/A | |
14 Nov, 2024 | 10-Q/A | |
6 Nov, 2024 | SC 13G/A | |
4 Nov, 2024 | 424B5 | |
4 Nov, 2024 | 424B3 | |
1 Nov, 2024 | EFFECT | |
1 Nov, 2024 | DEFA14A | |
1 Nov, 2024 | 8-K | |
31 Oct, 2024 | CORRESP | |
29 Oct, 2024 | UPLOAD | |
28 Oct, 2024 | ARS | |
28 Oct, 2024 | DEFA14A | |
28 Oct, 2024 | DEF 14A | |
24 Oct, 2024 | S-3 | |
18 Oct, 2024 | SC 13G/A | |
16 Oct, 2024 | PRE 14A | |
15 Oct, 2024 | 8-K | |
11 Oct, 2024 | SC 13G | |
7 Oct, 2024 | 4 | |
7 Oct, 2024 | SC 13G/A | |
2 Oct, 2024 | 4 | |
19 Sep, 2024 | 4 | |
19 Sep, 2024 | SC 13D/A | |
17 Sep, 2024 | 424B3 | |
16 Sep, 2024 | CORRESP | |
16 Sep, 2024 | EFFECT | |
13 Sep, 2024 | S-1/A | |
6 Sep, 2024 | 8-K | |
4 Sep, 2024 | S-1 | |
19 Aug, 2024 | 424B3 | |
16 Aug, 2024 | 8-K | |
13 Aug, 2024 | SC 13G/A | |
13 Aug, 2024 | 3 | |
12 Aug, 2024 | 10-Q | |
8 Aug, 2024 | 8-K | |
7 Aug, 2024 | 8-K | |
11 Jul, 2024 | 8-K/A | |
1 Jul, 2024 | 8-K | |
11 Jun, 2024 | 4 | |
11 Jun, 2024 | 4 | |
31 May, 2024 | 8-K | |
16 May, 2024 | 424B3 | |
15 May, 2024 | 4 | |
15 May, 2024 | 4 | |
14 May, 2024 | 10-Q | |
2 May, 2024 | POS AM | |
2 May, 2024 | EFFECT | |
24 Apr, 2024 | 4 | |
24 Apr, 2024 | 4 | |
24 Apr, 2024 | 4 | |
16 Apr, 2024 | 10-K | |
16 Apr, 2024 | 8-K | |
1 Apr, 2024 | NT 10-K | |
12 Feb, 2024 | SC 13G/A | |
8 Feb, 2024 | SC 13G/A | |
2 Feb, 2024 | SC 13G/A | |
10 Jan, 2024 | S-8 | |
18 Dec, 2023 | 424B3 | |
15 Dec, 2023 | EFFECT | |
14 Dec, 2023 | 4 | |
13 Dec, 2023 | CORRESP | |
5 Dec, 2023 | 4 | |
5 Dec, 2023 | 4 | |
5 Dec, 2023 | 4 | |
5 Dec, 2023 | 4 | |
5 Dec, 2023 | 4 | |
5 Dec, 2023 | 4 | |
1 Dec, 2023 | CORRESP | |
1 Dec, 2023 | S-8 | |
1 Dec, 2023 | S-1/A | |
21 Nov, 2023 | 10-Q/A | |
20 Nov, 2023 | 10-Q | |
14 Nov, 2023 | NT 10-Q | |
30 Oct, 2023 | UPLOAD | |
17 Oct, 2023 | S-1 | |
5 Oct, 2023 | 8-K/A | |
2 Oct, 2023 | SC 13G | |
29 Sep, 2023 | SC 13D | |
29 Sep, 2023 | SC 13D/A | |
29 Sep, 2023 | SC 13G | |
29 Sep, 2023 | 8-K | CEO Change |
26 Sep, 2023 | 3 | |
26 Sep, 2023 | 3 | |
26 Sep, 2023 | 3 | |
26 Sep, 2023 | 3 | |
26 Sep, 2023 | 3 | |
26 Sep, 2023 | 3 | |
26 Sep, 2023 | 4 | |
26 Sep, 2023 | 4 | |
22 Sep, 2023 | CERT | |
22 Sep, 2023 | 25-NSE | |
22 Sep, 2023 | 8-A12B | |
21 Sep, 2023 | 8-K | |
13 Sep, 2023 | 424B3 | |
13 Sep, 2023 | 425 | |
13 Sep, 2023 | 8-K | |
7 Sep, 2023 | 8-K | |
7 Sep, 2023 | 425 | |
31 Aug, 2023 | 8-K | |
31 Aug, 2023 | 425 | |
23 Aug, 2023 | 8-K | |
23 Aug, 2023 | 424B3 | |
23 Aug, 2023 | 425 | |
16 Aug, 2023 | 8-K | |
16 Aug, 2023 | 425 | |
14 Aug, 2023 | 10-Q | |
11 Aug, 2023 | EFFECT | |
11 Aug, 2023 | 424B3 | |
11 Aug, 2023 | SEC STAFF | |
10 Aug, 2023 | CORRESP | |
8 Aug, 2023 | CORRESP | |
8 Aug, 2023 | S-4/A | |
7 Aug, 2023 | UPLOAD | |
28 Jul, 2023 | CORRESP | |
28 Jul, 2023 | S-4/A | |
21 Jul, 2023 | 425 | |
21 Jul, 2023 | 8-K | |
20 Jul, 2023 | UPLOAD | |
11 Jul, 2023 | S-4/A | |
11 Jul, 2023 | CORRESP | |
31 May, 2023 | UPLOAD | |
30 May, 2023 | SEC STAFF | |
15 May, 2023 | 10-Q | |
12 May, 2023 | S-4 | |
12 May, 2023 | CORRESP | |
11 May, 2023 | 425 | |
11 May, 2023 | 8-K | |
14 Apr, 2023 | 8-K | |
28 Mar, 2023 | 10-K | |
8 Mar, 2023 | 8-K | |
1 Mar, 2023 | UPLOAD | |
16 Feb, 2023 | SC 13D | |
14 Feb, 2023 | SC 13G/A | |
10 Feb, 2023 | SC 13G | |
10 Feb, 2023 | SC 13G | |
8 Feb, 2023 | SC 13G/A | |
8 Feb, 2023 | 3 | |
3 Feb, 2023 | 8-K | |
1 Feb, 2023 | DRS | |
1 Feb, 2023 | 8-K | |
30 Jan, 2023 | 425 | |
30 Jan, 2023 | 8-K | |
30 Jan, 2023 | SC 13D/A | |
3 Jan, 2023 | DEF 14A | |
23 Dec, 2022 | PRE 14A | |
25 Nov, 2022 | UPLOAD | |
23 Nov, 2022 | CORRESP | |
21 Nov, 2022 | UPLOAD | |
14 Nov, 2022 | 8-K | |
14 Nov, 2022 | 425 | |
8 Nov, 2022 | 425 | |
8 Nov, 2022 | 8-K | |
7 Nov, 2022 | 10-Q | |
11 Aug, 2022 | 10-Q | |
18 May, 2022 | 10-Q | |
16 May, 2022 | NT 10-Q | |
29 Mar, 2022 | 10-K | |
28 Mar, 2022 | 8-K | |
14 Feb, 2022 | 8-K | |
14 Feb, 2022 | SC 13D | |
11 Feb, 2022 | 3 | |
11 Feb, 2022 | 3 | |
11 Feb, 2022 | 3 | |
11 Feb, 2022 | 3 | |
11 Feb, 2022 | 3 | |
11 Feb, 2022 | 3 | |
11 Feb, 2022 | 3 | |
11 Feb, 2022 | SC 13G | |
10 Feb, 2022 | SC 13G | |
8 Feb, 2022 | 8-K | |
4 Feb, 2022 | 424B5 | |
4 Feb, 2022 | SC 13G | |
2 Feb, 2022 | EFFECT | |
1 Feb, 2022 | CORRESP | |
1 Feb, 2022 | CORRESP | |
28 Jan, 2022 | S-1/A | |
26 Jan, 2022 | CORRESP | |
26 Jan, 2022 | RW WD | |
26 Jan, 2022 | RW | |
25 Jan, 2022 | CERT | |
24 Jan, 2022 | 8-A12B | |
21 Jan, 2022 | CORRESP | |
21 Jan, 2022 | CORRESP | |
6 Jan, 2022 | S-1 | |
20 Dec, 2021 | UPLOAD | |
9 Dec, 2021 | DRS |
Last update:2025-03-06 12:18:27.553424
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.